TrialThe Lancet. Microbe2022

Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial.

Eric Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.